Cohorts, LNG-01, Winter 2027.
Longevity and Senescence, Inaugural Cohort. Twelve weeks on longevity biology through a peptide lens. Senescence, autophagy, GH axis modulation, inflammaging, and practical longevity protocols. Live weekly with faculty, biweekly case review, and cohort workspace.
Announced, enrollment opens in Phase 2. Runs 2027-01-11 through 2027-04-05, 12 weeks. Led by David Amberg, MD, PhD , with Elena Brown, PharmD.
Be notified when enrollment opens. Or request access to be notified.
At a Glance
- Code LNG-01
- Length 12 weeks
- Seats 24 maximum, 24 remaining
- Price $2,400, illustrative
- Lead David Amberg, MD, PhD
- Co-Lead Elena Brown, PharmD
Curriculum
Twelve weeks, one topic per week. Case review clinic sessions are woven in on weeks 5, 8, and 12. The schedule is firm; topics may be refined based on the working cases in a given cohort.
- Wk 1 Frameworks of longevity, what is actually being modified
- Wk 2 Senescence pathways, senolytic peptides
- Wk 3 Autophagy, fasting mimetics, peptide adjuncts
- Wk 4 GH axis, CJC, ipamorelin, and the safety envelope
- Wk 5 Case review clinic, first session
- Wk 6 Inflammaging, thymic peptides
- Wk 7 Mitochondrial longevity interventions
- Wk 8 Case review clinic, second session
- Wk 9 Omics biomarkers for longitudinal tracking
- Wk 10 Safety and contraindications across age cohorts
- Wk 11 Protocol design, integration with lifestyle
- Wk 12 Final case review, cohort close
Scheduled Sessions
First sessions are confirmed and on the calendar. Remaining weeks are published closer to the cohort start.
Who This Is For
Practicing clinicians and scientists who want weekly faculty contact on a single therapeutic area, and who are willing to present anonymized cases for discussion. Not a primer. Comfort with the self-paced foundational material is assumed; a member can work through the public curriculum before applying.